Kaposi M, 1872. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph (Prague) 4 :265–273.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS, 1994. Identification of new herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266 :1865–1869.
Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK, 2002. Kaposi’s sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 47 :641–655.
Antman K, Chang Y, 2000. Kaposi’s sarcoma. N Engl J Med 342 :1027–1038.
Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P, 2001. Biology of Kaposi’s sarcoma. Eur J Cancer 37 :1251–1269.
Paredes-Pacheco E, Albújar P, 1968. Sarcoma de Kaposi: Comunicación de un caso. Revista del Cuerpo Médico 7 :451–454.
Maita RB, Meléndez RA, Seminario V, 1985. Factor VIII en Sarcoma de Kaposi y Verruga Peruana. Galeno 15 :14–17.
Echegaray A, Zaharia M, Barriga L, Moscol A, Heredia A, Barriga O, Pinillos AL, Almonte M, 1996. Sarcoma de Kaposi: Características epidemiológicas. Acta Cancerol (Lima) 26 :14–19.
Valverde J, Albújar P, 1998. Sarcoma de Kaposi clásico: Comunicación de dos casos de presentación inusual. Revista Médica de Trujillo 2 :5–6.
Lebbé C, 1998. Human herpesvirus 8 as the infectious cause of Kaposi sarcoma. Arch Dermatol 134 :736–738.
Foreman K, 2001. Kaposi’s sarcoma: The role of HHV-8 and HIV-1 in pathogenesis. Expert Rev Mol Med 2001 :1–17.
Hengge UR, Ruzicka T, Tyring S, Stuschke M, Roggendorf M, Schwartz RA, Seeber S, 2002. Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet 2 :281–292.
Neipel F, Fleckenstein B, 1999. The role of HHV-8 in Kaposi’s sarcoma. Semin Cancer Biol 9 :151–164.
Verma S, Robertson E, 2003. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222 :155–163.
García A, Olivella F, Valderrama S, Rodríguez G, 1989. Kaposi’s sarcoma in Colombia. Cancer 64 :2393–2398.
Yermiahu T, Benharroch D, 1994. Coomb’s-positive hemolytic anemia and tuberculosis in Kaposi’s sarcoma treated with interferon. Harefuah 127 :445–448.
Laatiri MA, Denguezli M, Mokni M, Chehata S, Elomri H, Nouira R, Korbi S, Ennabli S, 1998. Maladie de Hodgkin associee a un sarcome de Kaposi et une tuberculose des organes hematopoietiques. Tunis Med 76 :481–483.
Wang AY, Li PK, To KF, Lai FM, Lai KN, 1998. Coexistence of Kaposi’s sarcoma and tuberculosis in a renal transplant recipient. Transplantation 66 :115–118.
Krayem AB, Abdullah LS, Raweily EA, Wali SO, Rawas MM, Samman YS, Batouk AA, 2001. The diagnostic challenge of pulmonary Kaposi’s sarcoma with pulmonary tuberculosis in a renal transplant recipient: A case report. Transplantation 71 :1488–1491.
Chen YJ, Shieh PP, Shen JL, 2000. Orificial tuberculosis and Kaposi’s sarcoma in an HIV-negative individual. Clin Exp Dermatol 25 :393–397.
Chatlynne L, Ablashi D, 1999. Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9 :174–185.
Plancoulaine S, Abel L, Gessain A, 2002. Epidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus). Pathol Biol 50 :496–502.
Schulz T, Sheldon J, Greensill J, 2002. Kaposi’s sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). Virus Res 82 :115–126.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1321 | 1255 | 16 |
Full Text Views | 267 | 7 | 0 |
PDF Downloads | 56 | 8 | 0 |
Kaposi’s sarcoma (KS) has been classified in four clinical variants (classic or Mediterranean; endemic or African; epidemic or AIDS-related; iatrogenic or immunosuppression-related). Human herpesvirus 8 (HHV-8), has been found in all these variants. We herein discuss the unusual presentation of a 53-year-old indigenous patient with purplish-brown nodular lesions on lower extremities, and miliary tuberculosis. ELISA-HIV tests were negative and immunohistochemistry (IHC) of the tumor tissue was positive for HHV-8. This is the first reported case in which the presence of HHV-8 was evidenced by means of IHC techniques in Peru. We also review all available Peruvian literature of classic KS, a disease that has been frequently reported in indigenous population of Peru since 1968, making this country a possible endemic zone of classic KS.
Kaposi M, 1872. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph (Prague) 4 :265–273.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS, 1994. Identification of new herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266 :1865–1869.
Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK, 2002. Kaposi’s sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 47 :641–655.
Antman K, Chang Y, 2000. Kaposi’s sarcoma. N Engl J Med 342 :1027–1038.
Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P, 2001. Biology of Kaposi’s sarcoma. Eur J Cancer 37 :1251–1269.
Paredes-Pacheco E, Albújar P, 1968. Sarcoma de Kaposi: Comunicación de un caso. Revista del Cuerpo Médico 7 :451–454.
Maita RB, Meléndez RA, Seminario V, 1985. Factor VIII en Sarcoma de Kaposi y Verruga Peruana. Galeno 15 :14–17.
Echegaray A, Zaharia M, Barriga L, Moscol A, Heredia A, Barriga O, Pinillos AL, Almonte M, 1996. Sarcoma de Kaposi: Características epidemiológicas. Acta Cancerol (Lima) 26 :14–19.
Valverde J, Albújar P, 1998. Sarcoma de Kaposi clásico: Comunicación de dos casos de presentación inusual. Revista Médica de Trujillo 2 :5–6.
Lebbé C, 1998. Human herpesvirus 8 as the infectious cause of Kaposi sarcoma. Arch Dermatol 134 :736–738.
Foreman K, 2001. Kaposi’s sarcoma: The role of HHV-8 and HIV-1 in pathogenesis. Expert Rev Mol Med 2001 :1–17.
Hengge UR, Ruzicka T, Tyring S, Stuschke M, Roggendorf M, Schwartz RA, Seeber S, 2002. Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet 2 :281–292.
Neipel F, Fleckenstein B, 1999. The role of HHV-8 in Kaposi’s sarcoma. Semin Cancer Biol 9 :151–164.
Verma S, Robertson E, 2003. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222 :155–163.
García A, Olivella F, Valderrama S, Rodríguez G, 1989. Kaposi’s sarcoma in Colombia. Cancer 64 :2393–2398.
Yermiahu T, Benharroch D, 1994. Coomb’s-positive hemolytic anemia and tuberculosis in Kaposi’s sarcoma treated with interferon. Harefuah 127 :445–448.
Laatiri MA, Denguezli M, Mokni M, Chehata S, Elomri H, Nouira R, Korbi S, Ennabli S, 1998. Maladie de Hodgkin associee a un sarcome de Kaposi et une tuberculose des organes hematopoietiques. Tunis Med 76 :481–483.
Wang AY, Li PK, To KF, Lai FM, Lai KN, 1998. Coexistence of Kaposi’s sarcoma and tuberculosis in a renal transplant recipient. Transplantation 66 :115–118.
Krayem AB, Abdullah LS, Raweily EA, Wali SO, Rawas MM, Samman YS, Batouk AA, 2001. The diagnostic challenge of pulmonary Kaposi’s sarcoma with pulmonary tuberculosis in a renal transplant recipient: A case report. Transplantation 71 :1488–1491.
Chen YJ, Shieh PP, Shen JL, 2000. Orificial tuberculosis and Kaposi’s sarcoma in an HIV-negative individual. Clin Exp Dermatol 25 :393–397.
Chatlynne L, Ablashi D, 1999. Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9 :174–185.
Plancoulaine S, Abel L, Gessain A, 2002. Epidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus). Pathol Biol 50 :496–502.
Schulz T, Sheldon J, Greensill J, 2002. Kaposi’s sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). Virus Res 82 :115–126.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1321 | 1255 | 16 |
Full Text Views | 267 | 7 | 0 |
PDF Downloads | 56 | 8 | 0 |